21-hydroxylase deficiency risk factors: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Congenital adrenal hyperplasia due to 21-hydroxylase deficiency}} | {{Congenital adrenal hyperplasia due to 21-hydroxylase deficiency}} | ||
{{CMG}} {{AE}} {{AAM}} | |||
==Overview== | |||
The most potent risk factor in the development of 21-hydroxylase deficient congenital adrenal hyperplasia is [[Mutation]]s in the '''CYP21A2''' gene. | |||
==Risk Factors== | |||
[[Mutation]]s in the '''CYP21A2''' gene cause 21-hydroxylase deficient congenital adrenal hyperplasia. | |||
== References == | == References == | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
Revision as of 14:25, 4 September 2015
|
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency Microchapters |
|
Differentiating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
21-hydroxylase deficiency risk factors On the Web |
|
American Roentgen Ray Society Images of 21-hydroxylase deficiency risk factors |
|
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency |
|
Risk calculators and risk factors for 21-hydroxylase deficiency risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
The most potent risk factor in the development of 21-hydroxylase deficient congenital adrenal hyperplasia is Mutations in the CYP21A2 gene.
Risk Factors
Mutations in the CYP21A2 gene cause 21-hydroxylase deficient congenital adrenal hyperplasia.